Drug Giant Could Help Boost Biotech ETF Rally

biotechThe last time Celgene Corporation (NASDAQ:CELG) reported earnings back in April, Wall Street analysts were not too enthused with the cautious tone from management (nor the EPS and revenue guidance), which all came in below expectations.
NASDAQ:BLUE July 27, 2016 2:08pm

Big Biotech ETF Faces Key Technical Test

biotechDavid Fabian:  Those who have followed our blog for some time now know that we are big proponents of technical analysis in reading the trends of the market.  This type of examination can also be applied when we are analyzing individual sectors or industries that have diverged from the conventional path of the market.
NASDAQ:BIB March 18, 2016 3:10pm

Biotech Stocks Reach Bear Market Territory

biotechKyle Anderson:  The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.
ETF BASIC NEWS October 26, 2015 3:14pm

Biotech ETFs Offer A Great Buying Opportunity Right Now

biotechKyle Anderson:  Biotech stocks have gotten crushed in recent weeks, with the Nasdaq Biotechnology Index falling 15.5% in the last month and 25% from its July highs.
NASDAQ:BIB September 29, 2015 3:50pm

A Quality Biotech Stock Is Available On The Cheap

biotechMarshall Hargrave: Biotech stocks aren’t cheap. Dare I say, a biotech bubble might be brewing.
NASDAQ:IBB September 24, 2015 12:53pm

Amgen, Inc., Gilead Sciences, Inc., Biogen Inc, Celgene Corporation: Is A Biotech Bubble Looming?

dollar money bubbleJay Taylor: If you own shares of biotechnology stocks, chances are you’re having a great 2015.
NASDAQ:BIB April 14, 2015 2:55pm

Biogen Inc, Gilead Sciences, Inc., Amgen, Inc., Celgene Corporation: Are We In A Biotech Bubble?

biotechTyler Durden:  To let everyone’s favorite “diminutive” Fed chair tell it, biotech valuations have been “substantially stretched” for the better part of a year. Despite that, blockbuster M&A deals and IPOs for pre-revenue newcomers have managed to sustain
NASDAQ:BIB March 27, 2015 12:33pm

2015 Biotech ETF Surge Reflects Healthy Sector [Novavax, Inc., Biogen Idec Inc, Celgene Corporation, Gilead Sciences, Inc.]

biotechJim Bach: Popular biotech ETF First Trust NYSE Arca Biotechnology Index Fund (NYSE Arca: FBT) is up 23.5% on the year. It's among our top performing picks for year-to-date performance from our "stocks to invest in" list.
NASDAQ:BIB March 23, 2015 12:58pm

Celgene Corporation, Amgen, Inc., Alexion Pharmaceuticals, Inc.: Best Stocks To Play At This Time?

biotechMitchell Clark: One of the hottest areas of the stock market over the last few years has been one of its most speculative. Biotechnology stocks, as evidenced by the NASDAQ Biotechnology Index, have been on a tear for the last three years.
NASDAQ:BIB December 2, 2014 12:49pm

Healthy Returns From The Healthcare Sector [Biogen Idec Inc, Celgene Corporation, Gilead Sciences, Inc., Amgen, Inc.]

healthcare1Sy Harding: Healthcare stocks, along with the stocks of food and drink companies are often recommended as defensive holdings for recessions and bear markets, on the premise that no matter what happens people
NYSE:XLV November 15, 2014 11:17am

ETFs To Buy On Solid Biotech Stock Earnings [Celgene Corporation, Biogen Idec Inc, Alexion Pharmaceuticals, Inc., Amgen, Inc.]

biotechBiotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion
NASDAQ:BIB October 29, 2014 5:13pm

Biotech Stocks To Avoid [Pharmacyclics, Inc., Celgene Corporation, Amgen, Inc., Gilead Sciences, Inc.]

biotechKyle Anderson:  Investing in biotech stocks is risky for those who haven't done enough research. But with just a couple of tips, investors can drastically reduce the risk - and go on to benefit from massive windfalls generated by a company's breakthrough drug development.
NASDAQ:BIB October 1, 2014 10:10am

The Best Biotech Stocks To Buy Now [Gilead Sciences, Inc., Celgene Corporation, Biogen Idec Inc]

biotechMichael Robinson: If you had bought Biogen Idec Inc. (NASDAQ:BIIB) during the depths of this spring's biotech sell-off, you could have been sitting on peak gains of 28.3%.
NASDAQ:ONEQ September 16, 2014 10:14am

How To Ride The Biotech Stock Rally [Gilead Sciences, Inc., Celgene Corporation, SPDR S&P Biotech (ETF)]

biotechTyler Laundon: Just a few months ago in March 2014 the bears were out in full force calling for a biotech meltdown. The sector had been the best-performing one in the S&P 500 index for multiple years in a row. In 2013 alone, it bested the index by nearly 20%
NYSE:XBI August 21, 2014 3:44pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories